BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25901707)

  • 1. Complementary and alternative treatments for autism part 1: evidence-supported treatments.
    Bent S; Hendren RL
    AMA J Ethics; 2015 Apr; 17(4):369-74. PubMed ID: 25901707
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
    Nikoo M; Radnia H; Farokhnia M; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2015; 38(1):11-7. PubMed ID: 25580916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in autism.
    McGinnis WR
    Altern Ther Health Med; 2004; 10(6):22-36; quiz 37, 92. PubMed ID: 15624347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone for the core symptom domains of autism.
    Adetunji B; Mathews M; Osinowo T; Williams A
    Am J Psychiatry; 2006 Mar; 163(3):551; author reply 551-2. PubMed ID: 16513891
    [No Abstract]   [Full Text] [Related]  

  • 5. Indications.
    Oldham J
    J Psychiatr Pract; 2008 May; 14(3):133. PubMed ID: 18520781
    [No Abstract]   [Full Text] [Related]  

  • 6. Autism: biomedical complementary treatment approaches.
    Hendren RL
    Child Adolesc Psychiatr Clin N Am; 2013 Jul; 22(3):443-56, vi. PubMed ID: 23806313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone: a potential treatment for autism.
    Posey DJ; McDougle CJ
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary retention associated with aripiprazole: Report of a new case and review of the literature.
    Boyer MG; Kheloufi F; Denis J; Micallef J; Milh M
    Therapie; 2018; 73(3):287-289. PubMed ID: 29146041
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic drugs in children with autism.
    Morgan S; Taylor E
    BMJ; 2007 May; 334(7603):1069-70. PubMed ID: 17525405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of behavioral disorders by risperidone in children with autism].
    Wei BY; Huang F; Qin XT; Liang QQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar; 13(3):216-8. PubMed ID: 21426640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-methylfolate, methylcobalamin, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline.
    McCaddon A; Hudson PR
    CNS Spectr; 2010 Jan; 15(1 Suppl 1):2-5; discussion 6. PubMed ID: 20397369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone use in the treatment of behavioral symptoms in children with autism.
    West L; Waldrop J
    Pediatr Nurs; 2006; 32(6):545-9. PubMed ID: 17256292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in autism.
    McGinnis WR
    Altern Ther Health Med; 2005; 11(1):19. PubMed ID: 15712760
    [No Abstract]   [Full Text] [Related]  

  • 15. [N-Acetylcysteine: new possibilities to use an old substance].
    Ahola T; Lapatto R
    Duodecim; 1999; 115(4):375-9. PubMed ID: 11830885
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on: L-methylfolate, methylcobolamine, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline.
    Cummings JL
    CNS Spectr; 2010 Jan; 15(1 Suppl 1):7. PubMed ID: 20397370
    [No Abstract]   [Full Text] [Related]  

  • 17. Complementary and alternative treatments for autism part 2: identifying and avoiding non-evidence-based treatments.
    Singer A; Ravi R
    AMA J Ethics; 2015 Apr; 17(4):375-80. PubMed ID: 25901708
    [No Abstract]   [Full Text] [Related]  

  • 18. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
    McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug therapy in autism.
    Frischauf E
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):577. PubMed ID: 9136488
    [No Abstract]   [Full Text] [Related]  

  • 20. Risperidone in children with autism and serious behavioral problems.
    Sandler L
    N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12466518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.